Cardiovascular Endocrinology publishes peer-reviewed research in vascular disease, endocrinology, and metabolism. Particular emphasis is placed on studies that highlight the interaction between these disciplines.
The journal serves as a single resource for cardiology, endocrinology and metabolism research, and clinical communities. High-quality state-of-the-art reviews, invited editorials, and expert commentaries place original articles in context at the interface of basic and clinical research. Here we are pleased to introduce the journal’s guest editors for this issue.
Andrew Krentz, MD, FRCP, is Professor of Endocrinology & Metabolism and Director of the Institute for Translational Medicine in the Clore Life Sciences Laboratory at the University of Buckingham, UK. His clinical and research interests are focused on the pathophysiology and treatment of type 2 diabetes and the associated risk factors for vascular disease. In 2004–2005, Professor Krentz was the recipient of a British Heart Foundation international research fellowship at the University of California, San Diego, USA. He is an elected member of the British Hypertension Society and is accredited as a clinical specialist by the European Society for Hypertension. He is the founding Editor-in-Chief of Cardiovascular Endocrinology.
Dr Peter M. Nilsson is currently Professor of Clinical Cardiovascular Research at the Department of Clinical Sciences, Lund University, Sweden, based at the Skåne University Hospital in Malmö. He is mainly involved in research and clinical intervention studies related to the metabolic syndrome, insulin resistance, type 2 diabetes, new antidiabetes drugs, hypertension, and the early vascular ageing syndrome. For many years Dr Nilsson has been an active member of the European Society of Hypertension (ESH) and the ESH Working Group ‘Hypertension in Diabetes’. Since 2006 he has been a member of the ESH Council, responsible for the web page (http://www.eshonline.org), and has also acted as the Secretary of the ESH during 2009–2013. Dr Nilsson is also involved in quality assessment of diabetes care as a member of the data group for the National Diabetes Register of Sweden, with online registration of risk factor and treatment status of more than 300 000 patients annually. He has published more than 350 papers in peer-reviewed medical journals.